Here’s information about CareFusion, particularly its financial aspects and history as reflected in Google Finance and other sources:
CareFusion was a global medical technology corporation that developed, manufactured, and sold a wide array of products and services. These were designed to help hospitals and other healthcare providers improve the safety and efficiency of medication management, infection prevention, and respiratory care. Key product areas included infusion pumps, ventilation systems, surgical instruments, and medication dispensing systems.
CareFusion’s history involved a significant turning point: its spin-off from Cardinal Health in 2009. This separation was intended to allow CareFusion to focus more strategically on its core businesses in medical devices and technologies, while Cardinal Health could concentrate on its pharmaceutical distribution and services. Following the spin-off, CareFusion became a publicly traded company, listed on the New York Stock Exchange (NYSE) under the ticker symbol CFN. Google Finance tracked CareFusion’s stock performance, providing investors with real-time quotes, historical data, news articles, and financial reports.
Financially, CareFusion demonstrated consistent growth during its time as an independent entity. The company focused on innovation, acquisitions, and international expansion to drive revenue. For example, CareFusion strategically acquired smaller companies with complementary technologies to broaden its product portfolio and market reach. Financial metrics such as revenue, net income, and earnings per share (EPS) were closely monitored by investors. CareFusion regularly published quarterly and annual financial reports, which were readily accessible through sources like Google Finance and investor relations websites. These reports detailed the company’s financial performance, including sales figures by product segment and geographic region, as well as information on expenses, profitability, and cash flow.
A significant event in CareFusion’s history was its acquisition by Becton, Dickinson and Company (BD) in 2015. BD, a larger medical technology company, acquired CareFusion for approximately $12.2 billion. This acquisition was driven by strategic synergies, as it allowed BD to significantly expand its medication management and patient safety solutions. Following the completion of the acquisition, CareFusion ceased to exist as an independent publicly traded company, and its stock (CFN) was delisted from the NYSE. Therefore, Google Finance no longer provides real-time stock information for CareFusion. However, historical data remains accessible.
While CareFusion no longer exists as a separate entity, its legacy continues through BD. The products and technologies developed by CareFusion are now integrated into BD’s broader portfolio. The financial performance of those product lines are incorporated within BD’s overall financial reporting. Investors interested in the historical financial performance of CareFusion can still access historical data through Google Finance and other financial data providers, allowing them to analyze the company’s growth and profitability leading up to its acquisition by BD.